Navigation Links
Waters Corporation Receives Market Leadership and Product Innovation Awards
Date:10/22/2007

Frost & Sullivan Recognizes Achievements in Creating New Possibilities for

Science and Business

MILFORD, Mass., Oct. 22 /PRNewswire-FirstCall/-- Waters Corporation (NYSE: WAT) today announced that it has been awarded the 2007 Market Leadership Award and the 2007 Product Innovation Award by Frost & Sullivan. The Market Leadership award is in recognition of the Company's success and leadership in liquid chromatography (LC) and acknowledges the results that Waters technologies are having on business performance and on the advancement of science. The Product Innovation Award recognizes the Company's ability to take analytical science to the next level specifically with its laboratory informatics software portfolio and information management platforms.

"Having achieved leadership status in both segments of the U.S. liquid chromatography market, Waters is therefore a complete solutions provider for users employing liquid chromatography as a separations methodology," says Frost & Sullivan Research Analyst Shankar Sellappan, Ph.D. "Moreover, with additional uses and applications being developed for this technology, the company is set to benefit significantly in the future."

"In addition to designing, manufacturing and distributing UltraPerformance LC(R)(UPLC(R)), high performance liquid chromatography (HPLC) and mass spectrometry (MS) instrument systems and associated service and support products, Waters has also become a leading developer and supplier of software- based solutions," notes Frost & Sullivan Research Analyst Dr. Amarpreet Dhiman. "Frost & Sullivan believes that Waters is well placed to develop innovative, business critical software and versatile workflow management solutions by leveraging its leading position in existing markets."

"Receiving this recognition from Frost & Sullivan, is especially gratifying because it confirms our commitment to the success of the laboratory and the organizations that depend on them," said Rohit Khanna, Ph.D., Vice President of Worldwide Marketing, Waters Division. "Our informatics portfolio brings insight and decision-making power to scientific discovery and effective business management and continues to be the preferred choice for industry- leading companies."

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com.

About Waters Corporation (http://www.waters.com)

Waters Corporation (NYSE: WAT) creates business advantage for laboratory- dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, supported by an expert customer services team, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.28 billion in 2006 and 4,700 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Media Contacts:

Brian J. Murphy

Public Relations

Waters Corporation

508-482-2614

Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Ayurveda in troubled waters abroad.
2. Swimming in Troubled Waters
3. DDT Still Present In The Waters Of Los Angeles County
4. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
5. Infant receives first bloodless liver transplant
6. British MPs Say Prostate Cancer Receives Low Priority in the NHS
7. Fifth US Patient Receives Artificial Heart
8. Northfield Labs Receives FDA Comments
9. Abbott Receives CE Mark Certification
10. Zactima Receives Fast Track Designation By The FDA
11. East London Receives World Class New Private Hospital Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 2017 , ... Order Custom Tee Shirts Online , Welldonedesigns.com ... to be concerned about garment selection, expensive graphic designers, substandard printing, and shipping. ... and shipped within 5-10 days. And every garment we ship is shipped ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average ... phrase “more than any sane human could possibly complete,” then you’re all too familiar ... are desperately trying to be everything to everybody all the time. , Self-proclaimed overly ...
(Date:9/25/2017)... Grants Pass, OR (PRWEB) , ... September 25, ... ... good idea. Kleyne, host of the nationally syndicated The Sharon Kleyne Hour Power ... Tears® EyeMist®, would like us to shift our Olympic focus from a once-every-four-years ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... services supporting clinical research, today announces that 30 of its domain experts ... drug development lifecycle at upcoming industry conferences and webinars. Drawing on broad ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... to announce the next generation for LASIK in Manhattan with Contoura Vision, the ... technologically advanced laser systems available in the United States to correct nearsightedness and ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... Conference at the Grand Hyatt hotel in New York.  ... at 11:40 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology: